Impaired visual integration is well documented in schizophrenia and related to functional outcomes. However, it is unclear if this deficit is specific to schizophrenia, or characteristic of psychosis more broadly. To address this question, this study used a Bayesian model comparison approach to examine the evidence of three grouping models of visual integration performance in 116 individuals with schizophrenia (SZ), schizoaffective disorder (SA), bipolar disorder (BD) with or without a history of prominent psychosis (BDP+ and BDP-, respectively), or no psychiatric diagnosis (healthy controls; HC). We compared: (1) Psychosis Model (psychosis, non-psychosis), where the psychosis group included SZ, SA, and BDP+, and the non-psychosis group included BDP-and HC; (2) Schizophrenia Model (SZ, non-SZ); and (3) DSM Model (SZ, SA, BD, HC). The relationship between visual integration and general cognition was also explored. The Psychosis Model showed the strongest evidence, and visual integration was associated with general cognition in participants with psychosis. The results were consistent with the Research Domain Criteria (RDoC) framework, indicating that visual integration impairment is characteristic of psychosis and not specific to SZ or DSM categories, and may share similar disease pathways with observed neurocognitive deficits in psychotic disorders.
Introduction
Visual integration, the ability to combine discrete elements to form a holistic representation, underlies critical perceptual functions such as Gestalt grouping and is critical to cognitive processes within the environment (e.g., object identification, face processing; Butler et al., 2008) . Deficits in visual integration are well-documented in schizophrenia (SZ) and have been shown to be related to clinical symptoms, cognition, and functional outcomes (Silverstein et al., 2006 (Silverstein et al., ,1996 (Silverstein et al., ,2000 Tso et al., 2014 Tso et al., ,2012 Uhlhaas et al., 2006a Uhlhaas et al., ,2005 . Some evidence suggests that disruption in early perceptual processing may be one mechanism through which social functioning is compromised in SZ (Butler, 2009; Silverstein and Keane, 2011a) . Recent data show that visual integration impairment is evident in first-episode psychosis and worsens with illness chronicity (Keane et al., 2016) , suggesting that it may be a characteristic of psychosis or a function of illness severity rather than specific to the diagnostic category of schizophrenia. Given the functional and etiological relevance of visual integration in SZ and psychotic disorders, this question would have important implications for our understanding of the pathophysiology and treatment of severe mental illnesses. To this end, the current study aimed to test the diagnostic specificity of visual integration impairment in schizophrenia or psychosis.
Visual integration is an interactive process linking the bottom-up sensory data output of neurons that code local features of a scene to cells within downstream visual areas that code global and typically larger complex formations modulated by context and prior experiences. Within healthy individuals, effective visual integration relies on longrange connections in V2 or higher areas to produce grouping (Silverstein and Keane, 2011b) . Successful visual integration has been shown to be related to the N cl (closure negativity) event-related potentials (ERP) wave, localized in the lateral occipital complex (LOC; Butler et al., 2013) . However, proper functioning of the visual system also depends on top-down modulation of the visual cortex (Engel et al., 2001; Freeman et al., 2003; Gilbert and Li, 2013 ) and a balance in neuronal excitation/ inhibition, supported by NMDA receptor functions (e.g., to modulate lateral excitation) and GABAergic functions (e.g., to inhibit noise; Butler et al., 2008) . In fact, neural oscillations and synchronization, particularly at the beta and gamma frequency bands, are often implicated in visual processing and integration (Castelhano et al., 2015; Kloosterman et al., 2015; Uhlhaas et al., 2006) .
Visual integration can be psychophysically assessed with perceptual closure tasks, grouping paradigms, and, most commonly, a contour integration task that requires participants to identify a contour comprised of elements within a background of similar noise elements (Butler et al., 2008) . Individuals with SZ and psychosis typically perform worse than healthy controls on these tasks, suggesting impaired visual integration (review by Butler, 2009 ). The exact origin of visual integration deficits in psychosis is unclear. Distributed dysfunctions across the visual system, beginning from the retina (Adams and Nasrallah, 2017) , to primary visual cortex V1 (Anderson et al., 2017) , to extrastriate visual cortex V2-V4 (Butler et al., 2013; , and to associated visual areas in the dorsal and ventral processing streams (Butler et al., 2013; Green et al., 2015; Silverstein et al., 2015b) , have been reported. Regardless of the origin, visual integration impairment has been shown to be related to poorer social cognition and functional outcome in SZ (Silverstein and Keane, 2011b; Tso et al., 2014) , suggesting that visual abnormalities may have downstream effects on higher-level cognition and social functioning in SZ. Given the scientific rigor of its measurement and functional relevance in SZ, visual integration offers a unique window to examine and understand the pathophysiology of psychotic disorders.
One question that needs clarification in the literature is whether visual integration impairment is specific to schizophrenia or common to other psychiatric disorders. This question arises as the field is moving toward a dimensional understanding of psychopathologies, led by the National Institute of Mental Health Research Domain Criteria (RDoC) initiative. This shift away from diagnostic categories (e.g., Diagnostic and Statistical Manual for Mental Disorders; DSM) to functional dimensions linked with pathophysiology (e.g., visual perception; Insel et al., 2010; Insel, 2014 ) may improve our understanding of psychopathology through a data-driven approach. In line with this effort, visual integration has been examined in other psychiatric disorders with clinical manifestations suggesting abnormal visual perception, including body dysmorphic disorder and obsessive-compulsive disorder; however, no impairment was found in these disorders when compared with healthy controls and schizophrenia (Silverstein et al., 2015a) . It remains unclear, nevertheless, whether visual integration is affected in disorders in which psychosis is always present or highly prevalent, particularly those considered to be on the "schizophrenia-bipolar psychosis spectrum" (Keshavan et al., 2011) . Bipolar disorder (BD) is a disorder frequently (>50%) affected by psychosis (Keck et al., 2003) and has substantial clinical, cognitive, neurobiological, and genetic overlap with schizophrenia (Brown, 2015; Hall et al., 2015; Pearlson, 2015; Pearlson and Ford, 2014; Tondo et al., 2015) . Yet, no studies thus far have examined visual integration in BD. Additionally, there is evidence that BD patients with a history of psychosis (BDP+), compared with those without (BDP-), exhibit cognitive deficits (Hill et al., 2013; Ruocco et al., 2014) and neurobiological abnormalities (Ivleva et al., 2013; Mathew et al., 2014 ) similar in extent and severity to those observed in SZ. This suggests that the presence of psychosis, regardless of diagnostic category, might represent a distinct psychopathology that differentially impacts cognitive functions (including visual integration). Indeed, research studies often combine participants with SZ and schizoaffective disorder (SA) into one patient group, with the assumption that psychosis, rather than the DSM categories, is the underlying illness dimension causing the observed abnormalities of interest. This assumption is rarely explicitly tested in the schizophrenia literature, and visual integration is a well-researched topic in which the "schizophrenia" samples often comprise both SZ and SA (Butler et al., 2013; Chen et al., 2003; Silverstein et al., 2006) . This makes it difficult to determine if the two diagnostic groups do indeed exhibit similar deficits to support the schizophrenia or psychosis hypothesis of visual integration deficits. Taken together, to address the question of specificity of visual integration impairment to schizophrenia or psychosis, it is necessary to include BD and stratify it by history of psychosis, as well as separate SA from SZ.
The current study aims to address the question whether visual integration impairment is characteristic of psychosis in general, specific to schizophrenia, or a function of DSM diagnosis. We assessed visual integration using a contour integration task in 116 participants: three patient groups along the "schizophrenia-bipolar psychosis spectrum" (SZ, SA, BDP+), BDP-, and HC. Participants were grouped according to three distinct models: 1) The Psychosis Model (psychosis, non-psychosis), where the psychosis group included SZ, SA, and BDP+, and the non-psychosis group included BDP-and HC; 2) The Schizophrenia Model (SZ, non-SZ); and 3) The DSM Model (SZ, SA, BD, and HC). We then used Bayesian model comparison to determine which model was a more likely generative model of the observed visual integration performance data. We hypothesized that visual integration in the psychosis group would be worse than the non-psychosis group, and the Psychosis Model would be the winning model among the three competing models. Additionally, we examined the relationship between visual integration and cognitive measures within the psychosis group and hypothesized that poorer visual integration would be associated with worse cognitive functions.
Method

Participants
A total of 116 participants completed the study: 25 SZ, 22 SA, 31 BD, and 38 HC. Diagnostic and Statistical Manual of Mental DisordersFourth Edition (DSM-IV; American Psychiatric Association, 2000) diagnoses were established using the Structured Clinical Interview for the DSM-IV (SCID-IV; First et al., 1997) for SZ, SA, and HC participants. BD participants were originally recruited via a separate study, which characterized participants using the Diagnostic Interview for Genetic Studies (DIGS Version 4.0; Nurnberger et al., 1994) . BD participants were divided into two groups by history of prominent psychosis, defined as having had at least two mood episodes with psychotic features. Subsequently, 11 BD participants were assigned to the BDP+ group and 20 to the BDP-group. The clinical and HC groups were matched for age, sex, and parental education (Table 1) . Fifty-two participants of this study (29 SZ/SA and 23 HC) were part of a previous report . Eighty-seven participants of this study (37 SZ/SA, 27 BD, and 23 HC) participated in another study focusing on eye gaze perception, reported elsewhere (Yao et al., 2018) .
Participants were recruited via a university research registry, mental health clinics, other research studies, and advertisements. All participants were 18-65 years of age with at least 20/30 vision according to a Snellen chart. Participants who were unable to provide informed consent or had a history of substance dependence/abuse in the past 12 months were excluded. HC with a history of a DSM-IV Axis I diagnosis, significant medical conditions that affect brain functions, or family history of psychosis or mania among first-degree relatives were excluded. The study was conducted in accordance with the World Medical Association Declaration of Helsinki and the research protocol was approved by the Institutional Review Board of the University of Michigan Medical School. Written informed consent was obtained from each participant prior to data collection.
Visual integration
A Contour Integration task was used to measure visual integration. The task was presented on a Windows PC using MATLAB (MathWorks, Inc.). A chin-rest was used to maintain a distance of 16 inches between the computer screen and the participant. The stimulus was presented on T.B. Grove et al. Psychiatry Research 265 (2018) 271-278 Table 1 Demographic, clinical, cognitive characteristics and use of psychotropic medications of each group.
Group by diagnosis (281) 150 (50) 467 (570) 475 ( (Fig. 1) . The width of each Gabor element was 0.5°, and the Gabor wavelength was 2 cycles per degree. The distance between adjacent Gabor elements was 1°(SD = 0.1°), well below the 2°necessary for contour integration to occur without input of higher-level cognition (Ciaramelli et al., 2007; Mandon and Kreiter, 2005; Stettler et al., 2002) . The jitter angle of the contour-defining Gabor elements was manipulated so that larger degrees of jitter represent higher difficulty. This "jitter" method is recommended by the NIMH Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative (Carter and Barch, 2007) and used in validation studies of the Cognitive Neuroscience Test Reliability And Clinical applications for Schizophrenia (CNTRACS) Consortium (Butler et al., 2012 (Butler et al., ,2008 Gold et al., 2012; Sheffield et al., 2014; Silverstein et al., 2012; Strauss et al., 2014) . In each trial, stimuli were presented for 5 s and participants had to respond within this range. Participants were instructed to guess if uncertain. The task implemented a 3-up-1-down staircase method and was terminated after 12 performance reversals. For the first 2 reversals, the degree of jitter changed by units of 10°per reversal, and 5°per reversal for the remaining trials. The jitter degrees of the last 8 reversals were averaged to obtain a threshold. Participants completed a practice session (10 trials with feedback) followed by two blocks of the task. Thresholds for the two blocks were averaged to represent the overall threshold. Higher thresholds indicate better performance. Full methodological details of the task are available in Tso et al. (2014) .
Clinical symptoms
Clinical participants were assessed with the Scale for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984b) , Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1984a) , the revised version of the Beck Depression Inventory (BDI-IA; Beck and Steer, 1993) , and the Young Mania Rating Scale (YMRS; Young et al., 1978) . Young Mania Rating Scale (YMRS) data was not collected for participants who were part of a previous study of visual integration (see Tso et al., 2014) . The current study includes YMRS assessments of 27 BD participants along with 6 SZ and 12 SA participants.
General cognition
Participants completed the Brief Assessment of Cognition in Schizophrenia (BACS; Keefe, 1999) as a measure of general cognition. Standardized scores (z-scores) for BACS composite scores were computed with reference to test scores of 83 healthy individuals who are demographically similar to this study sample (41% female; average age = 42.2 ± 12.1 years; average years of education = 16.2 ± 2.4; average years of parental education = 14.8 ± 2.7 years).
Statistical analyses
Demographic and clinical differences between the psychosis and diagnostic groups were compared with one-way ANOVAs or chi-square tests. Tukey's HSD was used for post-hoc pairwise comparisons between the psychosis or diagnostic groups. Contour integration performance between groups within each of the three models (i.e., DSM, Schizophrenia, and Psychosis), along with the grouping of HC, BDP-, BDP+, SA, and SZ, was examined with one-way ANOVAs and Tukey HSD for post-hoc pairwise comparisons.
To address the question whether visual integration impairment is a characteristic of psychosis, specific to schizophrenia, or a function of DSM diagnosis, participants were grouped in three ways. The first grouping corresponds to the hypothesis that visual integration impairment is characteristic of psychosis (the "Psychosis Model"). As such, clinical participants were stratified by a history of prominent psychosis, resulting in a psychosis group (including SZ, SA, and BDP+) and a nonpsychosis group (including BDP-and HC). The second grouping corresponds to the hypothesis that visual integration impairment is specific to schizophrenia (the "Schizophrenia Model"), resulting in a schizophrenia group (SZ only) and a non-schizophrenia group (including SA, BD, and HC). The third grouping corresponds to the hypothesis that visual integration impairment is a function of DSM-IV diagnosis (the "DSM Model") resulting in four groups: SZ, SA, BD, and HC.
Bayesian model comparison was then used to determine which among the Psychosis Model, the Schizophrenia Model, or the DSM model, was a more likely generative model of the observed visual integration performance data among the 116 participants. Specifically, Bayes factor (BF) of an ANOVA model based on each grouping model (the numerator model), compared against a null model containing only intercept (the denominator model), was computed using the 'anovaBF' function in the R package 'BayesFactor' (Morey and Rouder, 2015) . BF is a ratio of the Bayesian evidence of two competing models. Because it accounts for both data fit and model complexity in the model comparison process, it is superior to comparing R 2 of two regression models in classical frequentist statistics, in which R 2 always increases as the number of predictors (in this case, groups) increases and thus the results would always favor the more complex model if everything else is held the same. In addition, because the three grouping systems being compared were not a reduced version(s) of one another, a model comparison approach based on hierarchical regression would not be applicable. The model with the highest BF was chosen as the winning model. Then, direct pairwise comparisons of the three models were performed by dividing the BF of one model by the BF of another model: Details of the R commands used and output of the Bayes factor analyses can be found in Supplementary Information 1. We interpreted the BF values following accepted guidelines (Jarosz and Wiley, 2014) . BF > 1 indicates evidence favoring the numerator model over the denominator model, while BF < 1 indicates evidence favoring the denominator model over the numerator model. Furthermore, BF between 1-3 provides "anecdotal" evidence for the Fig. 1 . Examples of the stimuli of the Contour Integration task. In each trial, a circle-like contour formed by Gabor elements is presented against a background of random Gabor elements. Participants were instructed to locate the contour (on the left or right side of the screen). Arrows denote the locations of the contours (not present in task). Difficulty increases as the jitter angle of the contour-defining elements increases (depicted from left to right panels).
T.B. Grove et al. Psychiatry Research 265 (2018) 271-278 numerator model, 3-10 "substantial" evidence, 10-30 "strong" evidence, 30-100 "very strong" evidence, and > 100 "decisive" evidence. Similarly, BF between 0.33 and 1 provide "anecdotal" evidence for the denominator model, 0.10 and 0.33 "substantial" evidence, 0.033 and 0.10 "strong" evidence, 0.01 and 0.033 "very strong" evidence, and < 0.01 "decisive" evidence. Due to the consideration that benzodiazepines may impact visual cortex activity (Butler et al., 2008) , the Bayesian analyses described above were repeated in participants not taking benzodiazepines (38 HC, 15 BDP-, 7 BDP+, 19 SA, and 21 SZ) for comparison purposes.
Finally, Pearson correlations were used to examine the relationships between visual integration and general cognition (BACS) and clinical variables (i.e., SAPS, SANS, and antipsychotic dose in daily chlorpromazine [CPZ] equivalents; Woods, 2003 Woods, , 2011 for those with a history of prominent psychosis.
Results
Demographic and clinical characteristics of the groups (by diagnosis and by history of prominent psychosis) are summarized in Table 1 . Performance on Contour Integration by each grouping model is illustrated in Fig. 2 . Results of one-way ANOVA showed a significant group effect when participants were divided into 5 different groups (SZ, SA, BDP + , BDP-, and HC), F(4,111) = 2.88, p = 0.026, and post-hoc pairwise group comparisons via Tukey HSD revealed that only SZ and HC were significantly different, p = 0.038 ( Fig. 2A) . A significant group effect was observed when participants were grouped according to psychosis, F(1,114) = 10.20, p = 0.002, as those with psychosis had significantly lower (worse) Contour Integration thresholds than those without psychosis (Fig. 2B) . When participants were grouped according to the Schizophrenia Model, the group effect did not reach statistical significance, F(1,114) = 3.43, p = 0.067. Finally, when participants were grouped according to the DSM Model (Fig. 2D) , a significant group effect was observed, F(3,112) = 3.66, p = 0.015, and post hoc comparisons indicated that SZ and SA both had significantly lower threshold than HC (p = 0.024 and p < 0.05, respectively).
Winning model of visual integration impairment
The Psychosis Model was the winning model, receiving the highest BF of 17.34 when compared against a null model, indicating "strong" evidence for a difference in Contour Integration according to a history of prominent psychosis. The Schizophrenia Model and DSM Model received a BF of 1.03 ("anecdotal" evidence) and 3.11 ("substantial" evidence), respectively.
The BF of the Psychosis Model vs. Schizophrenia Model was 16.89, and Psychosis Model vs. DSM Model was 5.58, indicating "strong" to "substantial" evidence favoring the Psychosis Model over the other two models, respectively. The BF of the DSM Model vs. Schizophrenia Model was 3.03, suggesting that the DSM model showed "substantially" more evidence than the Schizophrenia Model.
When BF analyses were repeated with participants not taking benzodiazepines, the findings were similar (see Supplementary Information 2).
Visual integration correlates in the psychosis group
Pearson correlation analysis showed that there was a significant relationship between Contour Integration and BACS (Fig. 3) . However, there were no significant correlations between Contour Integration and SAPS, SANS, or daily CPZ equivalents (p's > 0.05). 
Discussion
The current study compared three competing models of the specificity of visual integration impairment, namely the Psychosis Model, Schizophrenia Model, and the DSM Model. Results of Bayesian model comparisons based on data from 116 participants along the schizophrenia-bipolar-healthy spectrum indicated that the Psychosis Model was the winning model, showing evidence multiple times higher than the other two models. This suggests that visual integration impairment is characteristic of individuals with psychosis, rather than specific to the diagnostic category of SZ or a function of DSM diagnosis. Pairwise comparisons of the three models further revealed that although the DSM Model was far inferior to the Psychosis Model, it fit the data better than the Schizophrenia Model. This relative merit of the DSM Model likely arises from its implicit assumption that the presence of prominent psychosis represents to some degree illness severity or constitutes a distinct class of disease, as reflected in its distinction between SZ, SA, and BD made partially based on the history of psychosis. Overall, the results of this study provided unambiguous support that psychosis was an illness dimension driving the observed individual differences in visual integration performance.
Preliminary neuroimaging studies have provided some insight into the neural basis of visual integration deficits in psychosis. Silverstein and colleagues have shown that individuals with SZ exhibited underactivation in the extrastriate visual areas (V2-V4) when contour integration was difficult (i.e., higher jitter degree; , but hyperactivation in the lateral occipital complex when the task was easier (Silverstein et al., 2015b) . These findings suggest that deficient cortical activity in early visual areas and inefficiency of brain regions higher up in the visual processing stream may underlie the observed visual integration deficits in SZ. If these cortical dysfunctions are also present in those with a history of psychosis other than SZ (e.g., first-episode psychosis, SA, and BDP+), it would provide support that visual integration impairment observed in individuals with psychosis shares similar neural mechanisms. For example, in the context of visual processing of motion, similar brain dysfunction (reduced activation in the dorsal visual processing stream, including the superior parietal lobe) has been demonstrated in untreated first-episode schizophrenia and bipolar psychosis (Lencer et al., 2011) , providing support that neural deficits in the visual system are related to the etiology of psychosis. Probing specific biological abnormalities that have been hypothesized to be causal factors of visual integration impairment (e.g., glutamatergic or GABAergic dysfunctions; Butler et al., 2008) in individuals with psychosis across diagnostic categories would help determine their roles in visual integration deficits and identify potential biological targets for treatment.
Visual integration was associated with general cognition in psychosis, suggesting that visual integration plays a role in cognitive operations required to efficiently process important intellectual information. This finding provides a rationale for improving functional outcome in psychotic disorders through interventions targeting early visual processing. Considering that normal learning does occur in SZ during early visual processing tasks (Silverstein and Keane, 2009) , cognitive remediation focusing on visual integration tasks may improve occipital cortical functions and higher-order cognition that may be impacted by poor early visual processing in psychosis. Furthermore, given that the visual areas are relatively easy to localize and reach, applying brain stimulation such as transcranial direct-current stimulation (tDCS) and pairing it with neuroplasticity-based cognitive training (Nienow et al., 2016; Orlov et al., 2017) may be particularly applicable and help speed up the therapeutic process.
Previous findings indicate that more symptomatic SZ patients (especially those with more severe disorganization symptoms) show poorer early visual perceptual organization performance (Silverstein and Keane, 2011b ). We did not find significant correlations between visual integration and psychotic symptoms in the current study. Because the majority of our clinical participants were clinically stable outpatients, this null finding could simply reflect the limited range of symptom severity (especially for disorganization symptoms), which made it less likely to detect statistical relationships. In addition to including a larger sample with a wider range of symptom severity, future research should also examine whether visual integration deficits are proportional to illness severity or the relative prominence of psychosis throughout the course of illness. This would help further establish the notion of visual integration deficits as a function of psychosis. Existing assessment tools tend to focus on current symptoms only; research effort is required to develop reliable and valid tools to quantify these relevant dimensions of psychosis and consider the entire psychiatric history (including the prodromal phase) of the person instead of relying on a snapshot of the current state.
The use of mostly medicated patients in this study and previous studies presents the challenge of medication confounds. Preliminary findings of visual integration dysfunction in first-episode psychosis patients (Keane et al., 2016) provide some support that it is not merely caused by long-term medication use. However, these patients were all on antipsychotics and they showed less severe visual integration impairment when compared with chronic patients, making medication exposure still a possible, significant driving factor. Additionally, a significant portion (21%) of our patient sample (33% of the bipolar sample) were benzodiazepine users (60% of whom took this medication as needed). Benzodiazepines are known to affect cognition, including decreasing attention, slowing psychomotor response, and impairing memory (see for review Lader, 2014) . However, the effect of benzodiazepines on visual processing in psychosis is unclear and may be paradoxical; there is evidence that they may actually improve visual cortical function Tso et al., 2015) , potentially through normalizing pervasive GABAergic abnormalities found in the psychotic brain (Lewis, 2014) . We did not find correlation between visual integration performance and antipsychotic dose among the participants with psychosis, and the Bayes factor findings comparing the three grouping models were similar after excluding the 18% of our clinical sample who used benzodiazepines (regularly or as needed), providing some support that medications may not fully account for the findings of this study. However, the question of to what extent visual integration deficits could be attributed to psychosis per se or medication exposure would be best clarified in genetic and clinical high risk studies. Preliminary studies on whether contour perception deficits are present in unaffected first-degree relatives of schizophrenia patients have yielded conflicting findings (Keri et al., 2004; Schallmo et al., 2013) , and the presence of such deficts has yet to be investigated in ultra-high risk samples.
To summarize, this study tested the specificity of visual integration impairment to schizophrenia or psychosis using Bayesian model comparisons. Of the three grouping models tested (Psychosis Model, Schizophrenia Model, and DSM Model), the Psychosis Model showed the strongest evidence given the current data. Visual integration was found to be associated with general cognition in individuals with psychosis. The results together indicated that visual integration impairment is characteristic of psychosis and not specific to SZ or DSM categories, and may share common pathophysiologic pathways with abnormal neurocognition observed in psychosis. This study demonstrated that a Bayesian model comparison approach can be very useful in comparing competing disease categorization systems and extracting common psychopathological dimensions across diagnostic groups.
